We are live on ! Find out more
YARW

Yarrow Bioscience, Inc. Common Stock
YARW

98 hedge funds and large institutions have $160M invested in Yarrow Bioscience, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 53 increasing their positions, 7 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

657% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 7

73% more capital invested

Capital invested by funds: $92.7M → $160M (+$67.5M)

57% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 21

14% more funds holding

Funds holding: 86 → 98 (+12)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% less ownership

Funds ownership: 0.02% → 0.01% (-0%)

Holders
98
Holders Change
+12
Holders Change %
+13.95%
% of All Funds
2.01%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
33
Increased
53
Reduced
7
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$30.5M
2
Franklin Resources
Franklin Resources
California
+$12.7M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$11.3M
4
BlackRock
BlackRock
New York
+$9.88M
5
6CM
683 Capital Management
New York
+$6.68M

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$4.43M
2
VP
venBio Partners
California
-$3.92M
3
MP
Mangrove Partners
Connecticut
-$2.83M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.68M
5
O
OrbiMed
New York
-$2.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$667K -$47.4K -7 -6%
SSA
27
Schonfeld Strategic Advisors
New York
$657K +$711K +105 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$614K +$339K +50 +102%
Renaissance Technologies
29
Renaissance Technologies
New York
$535K +$582K +86 New
Ameriprise
30
Ameriprise
Minnesota
$520K +$366K +54 +193%
Charles Schwab
31
Charles Schwab
California
$495K +$352K +52 +193%
PVH
32
Psagot Value Holdings
Israel
$467K +$386K +57 +317%
SFI
33
Susquehanna Fundamental Investments
Pennsylvania
$446K +$488K +72 New
Jacobs Levy Equity Management
34
Jacobs Levy Equity Management
New Jersey
$411K +$352K +52 +371%
AllianceBernstein
35
AllianceBernstein
Tennessee
$367K +$399K +59 New
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$333K +$325K +48 +960%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$278K +$176K +26 +137%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$258K +$237K +35 +583%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$248K +$183K +27 +208%
Barclays
40
Barclays
United Kingdom
$219K +$196K +29 +483%
CL
41
CSS LLC
Illinois
$218K +$156K +23 +192%
Wells Fargo
42
Wells Fargo
California
$200K +$115K +17 +113%
Commonwealth Equity Services
43
Commonwealth Equity Services
Massachusetts
$179K +$6.77K +1 +4%
UBS Group
44
UBS Group
Switzerland
$178K +$122K +18 +164%
Goldman Sachs
45
Goldman Sachs
New York
$177K +$81.3K +12 +75%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$169K +$176K +26 +2,600%
BPA
47
Beacon Pointe Advisors
California
$166K +$183K +27 New
Dimensional Fund Advisors
48
Dimensional Fund Advisors
Texas
$164K -$135K -20 -43%
MA
49
MYDA Advisors
New York
$161K +$176K +26 New
HighTower Advisors
50
HighTower Advisors
Illinois
$152K +$169K +25 New
1
2
3 4 5

YARW Hedge Fund Activity: Q2 2020 in Review

98 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Yarrow Bioscience, Inc. Common Stock (YARW) for Q2 2020, worth a combined $160M — up 73% from $92.7M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new YARW positions and 21 closed out — a net gain of 12 holders — while 53 added to existing stakes and 7 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $30.5M. The largest seller was Great Point Partners, exiting entirely with an estimated $4.43M sold.

  • 98 institutional investors held Yarrow Bioscience, Inc. Common Stock (YARW) as of Q2 2020, up from 86 in Q1 2020.
  • Funds reported $160M of Yarrow Bioscience, Inc. Common Stock stock for Q2 2020, up 73% quarter-over-quarter.
  • 33 funds opened new Yarrow Bioscience, Inc. Common Stock positions in Q2 2020 and 21 closed out, a net change of +12 holders.
  • The largest Yarrow Bioscience, Inc. Common Stock buyer in Q2 2020 was Perceptive Advisors, an estimated $30.5M added.
  • The largest Yarrow Bioscience, Inc. Common Stock seller in Q2 2020 was Great Point Partners, an estimated $4.43M sold.

Based on aggregated 13F filings for Q2 2020.